Best Leukemia doctors in Israel: TOP 20 doctors

Leading leukemia specialist at Sourasky Medical Center (Ichilov) – Israel's largest and most advanced hospital.

• Over 24 years of experience of experience in hematology and oncology
• Fellowship-trained at a prestigious international center in New York
• Focuses on the latest medical treatments for leukemia
• Treats a high volume of complex blood cancer cases

Dr. Ram has performed several hundred stem cell transplants, a cornerstone treatment for leukemia, at Sourasky Medical Center.

• Board-certified in Hematology, Medical Oncology, and Internal Medicine
• Authored over 30 scientific articles and a medical textbook chapter
• Fellowship-trained in Hematology and Oncology at Westchester Medical Center
• Completed residency at the State University of New York at Brooklyn

Head of Pediatric Oncohematology at Dana Dwek Children's Hospital – Dr. El Hasid specializes in bone marrow and umbilical blood transplants for children.

• Performed 300+ transplant procedures
• Published 50+ research papers and 40 medical reports
• Trained at City of Hope Hospital in Los Angeles
• Member of American Hematology Association

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Shapira is a senior bone marrow transplantation specialist at the prestigious Sourasky Medical Center in Tel Aviv.

• Graduated from the Hebrew University Medical School in 1999
• Completed specialized internal medicine training at Hadassah Medical Center
• Senior physician in the Bone Marrow Transplantation department at Hadassah
• Fluent in English and Hebrew for international patients

Head of Hemato-Oncology Institute at Ichilov Medical Center – Professor Aviv specializes in leukemias and expert bone marrow transplantation.

• 34 years of experience of experience in oncohematology
• Leads the Bone Marrow Transplantation Department
• Senior physician at Ichilov since 2003
• Recognized expert in lymphomas and leukemias

Leads the pediatric hematology oncology department at Sourasky Medical Center, a major center for treating childhood leukemia in Israel.

• Over a decade of experience specializing in pediatric blood cancers
• Fellowship in pediatric hematology oncology at Schneider Children's Medical Center
• Specialized training abroad in bone and soft tissue oncology in Italy
• Coordinates sarcoma treatment for children, combining pediatric oncology with orthopedics
• Member of the Israeli Society of Pediatric Hematology Oncology

Dr. Herishanu's research and treatment focus is on chronic lymphocytic leukemia, the most common adult leukemia. He has received over ten national and international awards for his work in this field.

• Senior hematologist at Tel Aviv's Sourasky Medical Center
• Holds professional memberships with both Israeli and American Hematology Associations
• Completed his hematology residency at Tel Aviv Medical Center
• Published extensively on CLL treatment and research

Listed among Forbes' best doctors in Israel, Dr. Gal Goldstein leads the Pediatric Oncology and Hemato-Oncology Department at Hadassah Medical Center.

• Over 27 years of experience specializing in pediatric hemato-oncology
• Expert in haploidentical bone marrow transplantation
• Focus on retinoblastoma and precision medicine
• Member of four international pediatric oncology associations
• Trained at Tel Aviv University

Professor Zila Zuckerman is a dedicated hematology and transplantology specialist at Rambam Medical Center.

• Expert in adult and pediatric blood cancers
• Focuses on bone marrow transplantation for leukemia
• Part of a major academic medical center team

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Leads the Hematology Department at Hadassah Medical Center, where she specializes in advanced treatments for blood cancers.

• Professor with over three decades of experience in malignant blood diseases
• Trained for three years at Memorial Sloan-Kettering Cancer Center in New York
• Expert in bone marrow transplant and novel gene therapies
• First woman to serve as Dean of Hadassah School of Medicine
• Received the Healing with the Heart Award for exceptional patient care

Dr. Stepensky has performed over 3,500 bone marrow transplants and was recognized by Forbes as one of the best doctors.

• Specializes in treating children with leukemia and rare blood cancers
• 28 years of experience of dedicated practice in pediatric hematology
• Patients and parents call her the doctor who 'transplants life'

Dr. Spielberg is an oncohematologist specializing in blood cancers at Assuta Medical Center.

• Expertise focused specifically on leukemia and other blood disorders
• Based at Israel's prominent private hospital, Assuta Medical Center
• Provides integrated cancer care with access to advanced diagnostics

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.